Novel Antiplatelet Agents: ALX-0081, a Nanobody Directed towards von Willebrand Factor

Targeting von Willebrand factor as a novel anti-platelet therapy; Application of ARC1779, an Anti-vWF aptamer, against thrombotic risk

(2012) Ok-Nam Bae   ARCHIVES OF PHARMACAL RESEARCH

Circulation : Clinical Summaries

(2012)   CIRCULATION

Acute Coronary Syndromes: Diagnosis and Management, Part II

(2012) Amit Kumar et al.   MAYO CLINIC PROCEEDINGS

Contemporary use of glycoprotein IIb/IIIa inhibitors

(2012) Morten Würtz et al.   THROMBOSIS AND HAEMOSTASIS

von Willebrand Factor Inhibition Improves Endothelial Function in Patients with Stable Angina

(2012) Olivier Muller et al.   Journal of Cardiovascular Translational Research

Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs

(2011) H. Ulrichts et al.   BLOOD

Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

(2011) Giuseppe Patti et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of 600 Versus 300-mg Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Angioplasty

(2010) Fabio Mangiacapra et al.   AMERICAN JOURNAL OF CARDIOLOGY

Residual platelet reactivity: predicting short- and long-term clinical outcome in patients undergoing percutaneous coronary revascularization

(2010) Fabio Mangiacapra et al.   Biomarkers in Medicine

Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

(2010) G. Y. H. Lip et al.   EUROPEAN HEART JOURNAL

High Residual Platelet Reactivity After Clopidogrel

(2010) Fabio Mangiacapra et al.   JACC-Cardiovascular Interventions

Relation of Endothelial Function to Residual Platelet Reactivity After Clopidogrel in Patients With Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention

(2009) Olivier Muller et al.   AMERICAN JOURNAL OF CARDIOLOGY

Platelet receptors and signaling in the dynamics of thrombus formation

(2009) J. Rivera et al.   HAEMATOLOGICA

Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779

(2009) J. L. DIENER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Acute Coronary Syndromes: Diagnosis and Management, Part I

(2009) Amit Kumar et al.   MAYO CLINIC PROCEEDINGS

Relation of Low Response to Clopidogrel Assessed With Point-of-Care Assay to Periprocedural Myonecrosis in Patients Undergoing Elective Coronary Stenting for Stable Angina Pectoris

(2008) Thomas Cuisset et al.   AMERICAN JOURNAL OF CARDIOLOGY

Percutaneous Coronary Intervention for Chronic Stable Angina

(2008) David R. Holmes et al.   JACC-Cardiovascular Interventions

Direct Stenting for Stable Angina Pectoris Is Associated With Reduced Periprocedural Microcirculatory Injury Compared With Stenting After Pre-Dilation

(2008) Thomas Cuisset et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY